Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence.

Canadian Journal of Gastroenterology & Hepatology
Zhaohui BaiXingshun Qi

Abstract

Ascites, a common complication in cirrhosis, is prone to the development of acute kidney injury or hepatorenal syndrome and can be complicated by circulatory dysfunction after paracentesis. Terlipressin has not been considered as the mainstay treatment option for ascites in cirrhosis yet. The present work aimed to systematically review the current evidence regarding the use of terlipressin in cirrhosis with ascites and without hepatorenal syndrome. PubMed, EMBASE, and Cochrane Library databases were searched for relevant studies. Twelve studies were eligible. In 3 studies (1 randomized controlled trial and 2 single-arm studies without controls) involving 32 patients who received terlipressin for nonrefractory ascites, terlipressin improved hemodynamics by decreasing the heart rate and cardiac output and increasing the mean arterial pressure and systemic vascular resistance. In 5 studies (1 randomized controlled trial, 2 single-arm studies without controls, and 2 comparative studies with controls) involving 67 patients who received terlipressin for refractory ascites, terlipressin improved renal function by increasing the glomerular filtration rate, renal blood flow, urinary sodium, and urine output and decreasing serum creatini...Continue Reading

References

Sep 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R W SchrierJ Rodés
Feb 1, 1994·Seminars in Liver Disease·M BernardiG Gasbarrini
Jan 1, 1997·Seminars in Liver Disease·P GinèsJ Rodés
Aug 26, 1998·The New England Journal of Medicine·P Y MartinR W Schrier
Oct 5, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A CárdenasJ Rodés
Jun 28, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kevin P MooreVicente Arroyo
Dec 17, 2003·Journal of Gastroenterology and Hepatology·George TherapondosPeter C Hayes
Apr 16, 2004·The New England Journal of Medicine·Pere GinèsJuan Rodés
Jun 16, 2004·European Journal of Gastroenterology & Hepatology·Javier Sola-Vera, José Such
Jun 16, 2004·European Journal of Gastroenterology & Hepatology·Susanna CollRicard Solà
Feb 8, 2006·Journal of Gastroenterology and Hepatology·Virendra SinghArun K Sharma
Feb 24, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Richard Moreau, Didier Lebrec
Nov 4, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ramon PlanasRicard Solà
Dec 26, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Silvano FasolatoAngelo Gatta
Nov 22, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Aleksander KragFlemming Bendtsen
May 25, 2010·Liver International : Official Journal of the International Association for the Study of the Liver·Francesco SalernoSamuel S Lee
Jul 17, 2010·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver
Aug 11, 2010·Scandinavian Journal of Gastroenterology·Georgios N KalambokisEpameinondas V Tsianos
Nov 15, 2011·European Journal of Internal Medicine·Basilio FimianiAntonio Izzi
Jul 1, 2016·The American Journal of Gastroenterology·Paul J GowPeter W Angus

❮ Previous
Next ❯

Citations

Apr 12, 2021·Clinics in Liver Disease·Hélène LarrueChristophe Bureau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.